China Shineway Pharmaceutical Group Ltd
OTC:CSWYF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Shineway Pharmaceutical Group Ltd
OTC:CSWYF
|
CN |
|
E
|
E&M Co Ltd
KOSDAQ:089230
|
KR |
|
E
|
Everest Consolidator Acquisition Corp
NYSE:MNTN
|
US |
Wall Street
Price Targets
CSWYF Price Targets Summary
China Shineway Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for CSWYF is 0.921 USD with a low forecast of 0.912 USD and a high forecast of 0.948 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CSWYF's stock price target?
Price Target
0.921
USD
According to Wall Street analysts, the average 1-year price target for CSWYF is 0.921 USD with a low forecast of 0.912 USD and a high forecast of 0.948 USD.
What is China Shineway Pharmaceutical Group Ltd's Revenue forecast?
Projected CAGR
4%
For the last 14 years the compound annual growth rate for China Shineway Pharmaceutical Group Ltd's revenue is 3%. The projected CAGR for the next 2 years is 4%.
What is China Shineway Pharmaceutical Group Ltd's Operating Income forecast?
Projected CAGR
6%
For the last 14 years the compound annual growth rate for China Shineway Pharmaceutical Group Ltd's operating income is 0%. The projected CAGR for the next 2 years is 6%.
What is China Shineway Pharmaceutical Group Ltd's Net Income forecast?
Projected CAGR
5%
For the last 14 years the compound annual growth rate for China Shineway Pharmaceutical Group Ltd's net income is 2%. The projected CAGR for the next 2 years is 5%.
